0001168404-16-000038.txt : 20160829
0001168404-16-000038.hdr.sgml : 20160829
20160829171728
ACCESSION NUMBER: 0001168404-16-000038
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160829
DATE AS OF CHANGE: 20160829
EFFECTIVENESS DATE: 20160829
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC
CENTRAL INDEX KEY: 0001445499
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-269740
FILM NUMBER: 161858646
BUSINESS ADDRESS:
STREET 1: 915 EAST PINE ST
STREET 2: SUITE 401
CITY: SEATTLE
STATE: WA
ZIP: 98122
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 915 EAST PINE ST
STREET 2: SUITE 401
CITY: SEATTLE
STATE: WA
ZIP: 98122
D
1
primary_doc.xml
X0707
D
LIVE
0001445499
IMPEL NEUROPHARMA INC
915 EAST PINE ST
SUITE 401
SEATTLE
WA
WASHINGTON
98122
206-568-1466
DELAWARE
None
None
Corporation
true
John
D.
Hoekman
c/o Impel NeuroPharma, Inc.
915 East Pine St., Suite 401
Seattle
WA
WASHINGTON
98122
Executive Officer
Director
Stewart
Parker
c/o Impel NeuroPharma, Inc.
915 East Pine St., Suite 401
Seattle
WA
WASHINGTON
98122
Director
Other Health Care
Decline to Disclose
- 06b
false
2016-07-06
false
true
true
true
false
0
2000000
1090000
910000
false
4
0
0
0
false
IMPEL NEUROPHARMA INC
/s/ JOHN HOEKMAN
John Hoekman
President and CEO
2016-08-29